Table 1.
Biological Effect | KP Metabolite | Ref. |
---|---|---|
Anticonvulsant properties | KYNA, PIC | [28] |
Anti-inflammatory properties | 3HAA, 3HKyn | [28,42] |
Antimicrobial activity | KYN, KYNA, CA, PIC | [28,43] |
Antioxidant properties | KYNA, XA, AA, 3HKyn | [28,42,44] |
Antiviral properties | PIC | [28] |
Immunomodulation | KYN, CA | [28,43] |
Lipid peroxidation | QA | [45] |
Neurotoxicity | 3HKyn, QA | [42,45] |
Neuroprotective properties | KYNA | [28] |
Oxidative stress regulation | KYN, 3HKyn, 3HAA | [28] |
Proconvulsant properties | QA | [28] |
Pro-oxidant properties | 3HKyn, QA | [28,42] |
Reduction of lipid peroxidation | KYNA | [28] |
Transcription factor | KYN | [28] |
Vasodilator in endothelial cells | KYN | [28] |
AA—anthranilic acid; CA—cinnabarinic acid; 3HAA—3-hydroxyanthranilic acid; 3HKyn—3-hydroxykynurenine; KYN—kynurenine; KYNA—kynurenic acid; PIC—picolinic acid; QA—quinolinic acid; and XA—xanthurenic acid.